This document summarizes a webinar discussing efforts to reduce cancer among women of color. It provides background on breast and gynecological cancers rates and disparities among racial and ethnic groups. The webinar focused on a challenge to develop a mobile application to provide underserved and minority women with information on cancer prevention, screening, and treatment options in multiple languages. The application would allow interface with patient health records to provide reminders and support regarding preventive services timing.
IEx for Clinical Communication and Coordination: Health Department to Clinica...Catherine Schenck-Yglesias
AMIA 2012 Chicago Presymposium - WG-03: Current Issues for Population Health Informatics in Healthcare and Public Health - presentation by Joseph Gibson, MPH, PhD and Catherine Schenck-Yglesias, MHS
EHRs, PHRs, EMRs: Making Sense of the Alphabet SoupCHI*Atlanta
CHI*Atlanta's October program tackles health records and the potential of user experience to improve their adoption. Panelists include CDC, Kaiser Permanente, and Greenway Technologies. Hosted at Philips Design to cover public, private, and vendor perspectives.
Digital therapeutics and immersive technologies Bournemouth UniversityDavid Wortley
Digital therapeutics is a fast growing area of digital medicine. In this presentation, Vice President of the International Society of Digital Medicine (ISDM), David Wortley, sets out the current challenges to global health sustainability and the importance of shifting the focus from cure to prevention, especially in the use of digital technologies for personal health management and therapeutics.
The presentation includes examples of digital therapeutic applications for neuro- rehabilitation, gamified exercise using consumer VR devices and support for dementia sufferers through digital memories.
The presentation was delivered at the new Faculty for Health and Social Sciences at Bournemouth University.
IEx for Clinical Communication and Coordination: Health Department to Clinica...Catherine Schenck-Yglesias
AMIA 2012 Chicago Presymposium - WG-03: Current Issues for Population Health Informatics in Healthcare and Public Health - presentation by Joseph Gibson, MPH, PhD and Catherine Schenck-Yglesias, MHS
EHRs, PHRs, EMRs: Making Sense of the Alphabet SoupCHI*Atlanta
CHI*Atlanta's October program tackles health records and the potential of user experience to improve their adoption. Panelists include CDC, Kaiser Permanente, and Greenway Technologies. Hosted at Philips Design to cover public, private, and vendor perspectives.
Digital therapeutics and immersive technologies Bournemouth UniversityDavid Wortley
Digital therapeutics is a fast growing area of digital medicine. In this presentation, Vice President of the International Society of Digital Medicine (ISDM), David Wortley, sets out the current challenges to global health sustainability and the importance of shifting the focus from cure to prevention, especially in the use of digital technologies for personal health management and therapeutics.
The presentation includes examples of digital therapeutic applications for neuro- rehabilitation, gamified exercise using consumer VR devices and support for dementia sufferers through digital memories.
The presentation was delivered at the new Faculty for Health and Social Sciences at Bournemouth University.
Patient View - The need for user-defined guidelines for health appsIn The Pocket
Dee O' Sullivan is an advocate for user-defined guidelines for health apps. In this presentation, she tells us why these guidelines are an absolute need in the healthcare industry.
Medical Informatics Update 2013 Programpaulgoldfarb
Event program for the Medical Informatics Update 2013 held October 16, 2013 and sponsored by the Center for Advanced Information Management at Columbia University and IBM Healthcare.
Technology evolutions in disaster medicine - Crisis Response JournalEmily Hough
As medicine is always evolving, it is crucial for disaster medicine to apply technology, not as an exception, but as a necessity, Here is a glimpse of some ideas that might revolutionise disaster medicine in the future
Patient-Generated Data for Cancer Treatment and ManagementTommy Snitz
Research poster created by myself and Matthew Villarreal while we were students of The University of Texas at Austin's Health Informatics and Health IT Program.
Looks into the benefits and challenges of using patient-generated data in cancer treatment and management
Optimizing your EHR Value through Patient EngagementBrian Ahier
Focusing on the transformed healthcare system enabled by ARRA, hear ideas on how patients can help realize the value of your EHR and help you achieve meaningful use.
Judy Murphy, RN, FACMI, FHIMSS, FAAN
Deputy National Coordinator for Programs and Policy, Office of the National Coordinator for HIT
New Normal, New Future - Free Download E bookkevin brown
Healthcare is shifting from the traditional provider-centric,
in-patient setting to patient-centric, virtual consultations
with increased remote care monitoring. This transition
has prompted the need for MedTech industry to relook
at the products they develop and enhance value in care
delivery.
The COVID-19 pandemic has increased the use of
digital health technologies, and the need to develop
innovative devices or systems that support virtual
health. The last couple of years have seen increased
use of wearables, mobile and app-based technologies
along with data and analytics have been transforming
healthcare delivery.
Advancements in healthcare technologies like
Artificial Intelligence (AI), Virtual Reality and Augmented
Reality 3D-printing, robotics and nanotechnology are
shaping the future of healthcare. This technology boom
is helping address disease and medical conditions
through provision of cheaper, faster and more effective
solutions for diseases.
Karen Day, University of Auckland
Koray Atalag, University of Auckland
Denise Irvine, e3health
Bryan Houliston, Auckland University of Technology
(4/11/10, Illott, 1.45)
Information systems for health decision making - a citizen's perspectiveErdem Yazganoglu
We make health decisions everyday. We get our information from the Internet. As a society we are investing large amounts of funding for the health information systems. In this presentation, I tried to look from the perspective of a citizen and tried bringing a different perspective.
Created as a podcast for the Dental Informatics Online Community [http://www.dentalinformatics.com/], this is snapshot of what is going on with social technologies and Web 2.0 in various healthcare communities.
Patient View - The need for user-defined guidelines for health appsIn The Pocket
Dee O' Sullivan is an advocate for user-defined guidelines for health apps. In this presentation, she tells us why these guidelines are an absolute need in the healthcare industry.
Medical Informatics Update 2013 Programpaulgoldfarb
Event program for the Medical Informatics Update 2013 held October 16, 2013 and sponsored by the Center for Advanced Information Management at Columbia University and IBM Healthcare.
Technology evolutions in disaster medicine - Crisis Response JournalEmily Hough
As medicine is always evolving, it is crucial for disaster medicine to apply technology, not as an exception, but as a necessity, Here is a glimpse of some ideas that might revolutionise disaster medicine in the future
Patient-Generated Data for Cancer Treatment and ManagementTommy Snitz
Research poster created by myself and Matthew Villarreal while we were students of The University of Texas at Austin's Health Informatics and Health IT Program.
Looks into the benefits and challenges of using patient-generated data in cancer treatment and management
Optimizing your EHR Value through Patient EngagementBrian Ahier
Focusing on the transformed healthcare system enabled by ARRA, hear ideas on how patients can help realize the value of your EHR and help you achieve meaningful use.
Judy Murphy, RN, FACMI, FHIMSS, FAAN
Deputy National Coordinator for Programs and Policy, Office of the National Coordinator for HIT
New Normal, New Future - Free Download E bookkevin brown
Healthcare is shifting from the traditional provider-centric,
in-patient setting to patient-centric, virtual consultations
with increased remote care monitoring. This transition
has prompted the need for MedTech industry to relook
at the products they develop and enhance value in care
delivery.
The COVID-19 pandemic has increased the use of
digital health technologies, and the need to develop
innovative devices or systems that support virtual
health. The last couple of years have seen increased
use of wearables, mobile and app-based technologies
along with data and analytics have been transforming
healthcare delivery.
Advancements in healthcare technologies like
Artificial Intelligence (AI), Virtual Reality and Augmented
Reality 3D-printing, robotics and nanotechnology are
shaping the future of healthcare. This technology boom
is helping address disease and medical conditions
through provision of cheaper, faster and more effective
solutions for diseases.
Karen Day, University of Auckland
Koray Atalag, University of Auckland
Denise Irvine, e3health
Bryan Houliston, Auckland University of Technology
(4/11/10, Illott, 1.45)
Information systems for health decision making - a citizen's perspectiveErdem Yazganoglu
We make health decisions everyday. We get our information from the Internet. As a society we are investing large amounts of funding for the health information systems. In this presentation, I tried to look from the perspective of a citizen and tried bringing a different perspective.
Created as a podcast for the Dental Informatics Online Community [http://www.dentalinformatics.com/], this is snapshot of what is going on with social technologies and Web 2.0 in various healthcare communities.
FoodCare helps food and beverage businesses understand and meet the needs of millions of individuals and families by providing nutrition-related apps and services.
What Black Women Need to Know About Endometrial Cancerbkling
Dr. Kemi Doll, gynecologic oncologist at the University of Washington Medical Center, shares her passion for improving the lives of black women affected by this disease through her extensive research and knowledge about endometrial cancer.
This webinar is being put on in partnership with ECANA.
26th International Papillomavirus Conference: Satellite Symposium
Enhancing HPV Prevention among Indigenous Populations: International Perspectives on Health and Well-Being
Montreal, Quebec
July 5, 2010
Panel 2: Primary and Secondary Prevention of HPV Diseases, Cervical and other cancers among Indigenous Populations: Promising Interventions and Wise Practices.
Sharad Ghamande, MD, FACOG
Professor and Director of Gynecologic Oncology
Augusta University Cancer Center
Presentation to the Georgia Senate Women's Adequate Healthcare Study Committee
www.gacommissiononwomen.org
See how with the with the power of AI and leading big data tools, we have tech-enabled a way to turn all available open-source digital discussions into actionable insights and journeys that represent the unsolicited digital voice of the patient. Without the cost and time constraints of traditional research methods or limited social listening sources, we help you understand the mindset, behavioral and overall drivers and barriers impacting patient decisions and outcomes.
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...bkling
You’ve been treated for uterine cancer. Now what? With surveillance strategies varying from doctor to doctor, it can be hard to know which advice you should follow. Dr. Jennifer Mueller, Head of the Endometrial Cancer Section, Gynecologic Oncology Service at Memorial Sloan Kettering Cancer Center, delves into surveillance guidelines, which tests to consider, and how to keep an eye out for any symptoms which could indicate recurrence.
What Black Women Need to Know About Cervical Cancerbkling
Did you know that cervical cancer disproportionately affects Black women? Please join Dr. Gizelka David-West, a gynecologic oncologist at Northwell Health, to learn more about the causes, symptoms, screening, and prevention of the disease. Dr. David-West will also discuss the factors that contribute to the cervical cancer disparities among Black women and what can be done to address them.
Why are Breast Cancers More Aggressive in Black Women?bkling
There are striking disparities in survival rates between Black and white breast cancer patients. Our guest speakers, Christine Ambrosone, PhD, and Song Yao, MD, PhD, have led a team that has done extensive research to understand the causes of why certain cancers are more aggressive in Black women. They have developed a hypothesis that the higher rate of aggressive tumors in Black women when compared with white women might have something to do with their immune systems. We will get updates from their research and how we can work towards eliminating racial gaps in breast cancer survival.
Bridging Clinical Gaps and Disparities in Care in TNBCbkling
This webinar will focuses on racial, ethnic, and socioeconomic disparities with the clinical gaps in treatment for women with triple-negative breast cancer (TNBC). Our guest speaker Shonta Chambers, MSW, is the EVP of Health Equity and Community Engagement at the Patient Advocate Foundation and Principal Investigator for SelfMade Health Network. Come and learn about this complex subtype, barriers to care, address the myths and fears around clinical trials in specific racial and ethnic communities, and help bridge the clinical gaps to improve survival outcomes for patients with TNBC.
Annual Report to the Nation on the Status of Cancer,Part I .docxjack60216
Annual Report to the Nation on the Status of Cancer,
Part I: National Cancer Statistics
Kathleen A. Cronin, PhD, MPH1; Andrew J. Lake, BS2; Susan Scott, MPH 1; Recinda L. Sherman, MPH, PhD, CTR3;
Anne-Michelle Noone, MS1; Nadia Howlader, MS, PhD1; S. Jane Henley, MSPH4; Robert N. Anderson, PhD5;
Albert U. Firth, BS2; Jiemin Ma, PhD, MHS6; Betsy A. Kohler, MPH, CTR3; and Ahmedin Jemal, DVM, PhD 6
BACKGROUND: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer
Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate to provide annual updates
on cancer occurrence and trends in the United States. METHODS: Incidence data were obtained from the CDC-funded and NCI-
funded population-based cancer registry programs and compiled by NAACCR. Data on cancer deaths were obtained from the
National Center for Health Statistics National Vital Statistics System. Trends in age-standardized incidence and death rates for all can-
cers combined and for the leading cancer types by sex, race, and ethnicity were estimated by joinpoint analysis and expressed as the
annual percent change. Stage distribution and 5-year survival by stage at diagnosis were calculated for breast cancer, colon and rec-
tum (colorectal) cancer, lung and bronchus cancer, and melanoma of the skin. RESULTS: Overall cancer incidence rates from 2008 to
2014 decreased by 2.2% per year among men but were stable among women. Overall cancer death rates from 1999 to 2015
decreased by 1.8% per year among men and by 1.4% per year among women. Among men, incidence rates during the most recent 5-
year period (2010-2014) decreased for 7 of the 17 most common cancer types, and death rates (2011-2015) decreased for 11 of the 18
most common types. Among women, incidence rates declined for 7 of the 18 most common cancers, and death rates declined for 14
of the 20 most common cancers. Death rates decreased for cancer sites, including lung and bronchus (men and women), colorectal
(men and women), female breast, and prostate. Death rates increased for cancers of the liver (men and women); pancreas (men and
women); brain and other nervous system (men and women); oral cavity and pharynx (men only); soft tissue, including heart (men
only); nonmelanoma skin (men only); and uterus. Incidence and death rates were higher among men than among women for all racial
and ethnic groups. For all cancer sites combined, black men and white women had the highest incidence rates compared with other
racial groups, and black men and black women had the highest death rates compared with other racial groups. Non-Hispanic men
and women had higher incidence and mortality rates than those of Hispanic ethnicity. Five-year survival for cases diagnosed from
2007 through 2013 ranged from 100% (stage I) to 26.5% (stage IV) for female breast cancer, from 88.1% (stage I) to 12.6% (stage IV)
for colorectal cancer, from 55.
Annual Report to the Nation on the Status of Cancer,Part I .docxrossskuddershamus
Annual Report to the Nation on the Status of Cancer,
Part I: National Cancer Statistics
Kathleen A. Cronin, PhD, MPH1; Andrew J. Lake, BS2; Susan Scott, MPH 1; Recinda L. Sherman, MPH, PhD, CTR3;
Anne-Michelle Noone, MS1; Nadia Howlader, MS, PhD1; S. Jane Henley, MSPH4; Robert N. Anderson, PhD5;
Albert U. Firth, BS2; Jiemin Ma, PhD, MHS6; Betsy A. Kohler, MPH, CTR3; and Ahmedin Jemal, DVM, PhD 6
BACKGROUND: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer
Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate to provide annual updates
on cancer occurrence and trends in the United States. METHODS: Incidence data were obtained from the CDC-funded and NCI-
funded population-based cancer registry programs and compiled by NAACCR. Data on cancer deaths were obtained from the
National Center for Health Statistics National Vital Statistics System. Trends in age-standardized incidence and death rates for all can-
cers combined and for the leading cancer types by sex, race, and ethnicity were estimated by joinpoint analysis and expressed as the
annual percent change. Stage distribution and 5-year survival by stage at diagnosis were calculated for breast cancer, colon and rec-
tum (colorectal) cancer, lung and bronchus cancer, and melanoma of the skin. RESULTS: Overall cancer incidence rates from 2008 to
2014 decreased by 2.2% per year among men but were stable among women. Overall cancer death rates from 1999 to 2015
decreased by 1.8% per year among men and by 1.4% per year among women. Among men, incidence rates during the most recent 5-
year period (2010-2014) decreased for 7 of the 17 most common cancer types, and death rates (2011-2015) decreased for 11 of the 18
most common types. Among women, incidence rates declined for 7 of the 18 most common cancers, and death rates declined for 14
of the 20 most common cancers. Death rates decreased for cancer sites, including lung and bronchus (men and women), colorectal
(men and women), female breast, and prostate. Death rates increased for cancers of the liver (men and women); pancreas (men and
women); brain and other nervous system (men and women); oral cavity and pharynx (men only); soft tissue, including heart (men
only); nonmelanoma skin (men only); and uterus. Incidence and death rates were higher among men than among women for all racial
and ethnic groups. For all cancer sites combined, black men and white women had the highest incidence rates compared with other
racial groups, and black men and black women had the highest death rates compared with other racial groups. Non-Hispanic men
and women had higher incidence and mortality rates than those of Hispanic ethnicity. Five-year survival for cases diagnosed from
2007 through 2013 ranged from 100% (stage I) to 26.5% (stage IV) for female breast cancer, from 88.1% (stage I) to 12.6% (stage IV)
for colorectal cancer, from 55.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
The Catalyst @ Health 2.0/Wipfli Survey on the State of Digital Health 2021 -...health2dev
The final results are in! Take a look now to see the output of the analysis on the Catalyst @ Health 2.0/Wipfli Survey on the State of Digital Health - 2021!
The 2018 AMR API study from Health 2.0. A survey of the experience of the small health tech application companies working with the large EMR vendors. This is an update and expansion of a similar 2016 study. Both studies supported by the California Health Care Foundation.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
With support from California Health Care Foundation, earlier this year (2016) Health 2.0 surveyed over 100 small health tech companies to ask their experiences integrating with specific EMR vendors.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and product information make this quarterly release the cream of the freebie crop.
AMA & MGMA Practice Innovation Challenge Winnershealth2dev
This slide provides descriptions for the 5 winners of the AMA & MGMA Practice Innovation Challenge. The winners were announced at the MGMA 2015 Annual Conference. Winners will work work with the AMA to develop their proposal into a module for the AMA Steps Forward Website.
2. On
the
Call:
Dr.
David
Hunt,
Medical
Officer
-‐
ONC
Dr.
Paris
Butler,
Clinical
Advisory
to
the
Deputy
Assistant
Secretary
for
Minority
Health
Hemali
Thakkar,
Challenger
Manager
–
Health
2.0
Today’s
Agenda:
Introduc/ons
Brief
Challenge
Overview
Q&A
Office
of
the
Na/onal
Coordinator
for
2
Health
Informa/on
Technology
3. ONC
and
I2
Goals
• Better Health, Better Care, Better Value through Quality Improvement
• Further the mission of the Department of Health and Human Services
• Highlight programs, activities, and issues of concern
• Spur Innovation and Highlight Excellence
• Motivate, inspire, and lead
• Community building – Development of ecosystem
• Stimulate private sector investment
Office
of
the
Na/onal
Coordinator
for
3
Health
Informa/on
Technology
4. Over
300,000
new
breast
and
gynecologic
cancers
are
diagnosed
each
year
with
68,000
deaths
annually.
Office
of
the
Na/onal
Coordinator
for
4
Health
Informa/on
Technology
5. Breast
Cancer
hZp://www.cdc.gov/cancer/breast/
In
the
United
States
in
2008,*
210,203
women
were
diagnosed
with
breast
cancer,
and
40,589
women
died
from
the
disease.†
Except
for
skin
cancer,
breast
cancer
is
the
most
common
cancer
among
American
women.
*Latest
year
for
which
sta/s/cs
are
available.
†Source:
USCS.
Office
of
the
Na/onal
Coordinator
for
5
Health
Informa/on
Technology
6. Gynecologic
Cancers
Each
gynecologic
cancer
is
unique,
with
different
signs,
symptoms,
risk
factors
(things
that
may
increase
your
chance
of
geFng
a
disease),
and
prevenHon
strategies.
Every
year,
more
than
80,000
women
in
the
U.S.
are
told
they
have
a
gynecologic
cancer,
and
more
than
25,000
women
die
from
a
gynecologic
cancer.*
*Source:
U.S.
Cancer
Sta0s0cs
Working
Group
Office
of
the
Na/onal
Coordinator
for
6
Health
Informa/on
Technology
7. Age-‐Adjusted
Cancer
Incidence
and
Death
Rates:
Female
Breast
and
Gynecologic
by
and
Race
and
Ethnicity,
United
States
Asian/Pacific American Indian/
All Races White Black Islander Alaska Native Hispanic
Female Breast Cancer
Incidence 121.9 122.6 118 87.9 65.6 92.8
Female Breast Cancer Death
Rates 22.5 21.9 31.2 11.9 12.8 14.6
Female Gynecologic
Cancer Incidence 48.4 48.9 45.5 34.4 31.3 45.8
Female Gynecologic Cancer
Death Rates 15.5 15.3 18.9 10.3 11.9 12.6
Rates
are
per
100,000
persons
and
are
age-‐adjusted
to
the
2000
U.S.
standard
popula/on
(19
age
groups-‐Census
P25-‐1130).
hZp://apps.nccd.cdc.gov/uscs/cancersbyraceandethnicity.aspx
Office
of
the
Na/onal
Coordinator
for
7
Health
Informa/on
Technology
8. *Rates
are
per
100,000
persons
and
are
age-‐adjusted
to
the
2000
U.S.
standard
populaHon
(19
age
groups-‐Census
P25-‐1130).
140
120
Female
Breast
Incidence
Female
Genital
System
Incidence
100
80
60
40
20
0
All
Races
White
Black
Asian/Pacific
Islander
American
Indian/Alaska
Hispanic
Office
of
the
Na/onal
Coordinator
for
Na/ve
8
Health
Informa/on
Technology
9. *Rates
are
per
100,000
persons
and
are
age-‐adjusted
to
the
2000
U.S.
standard
populaHon
(19
age
groups-‐Census
P25-‐1130).
35
30
Female
Breast
Death
Rates
25
Female
Genital
Death
Rates
20
15
10
5
0
All
Races
White
Office
Black
Na/onal
Asian/Pacific
Islander
American
Indian/Alaska
Na/ve
of
the
Coordinator
for
Hispanic
9
Health
Informa/on
Technology
10. While
the
incidence
and
prevalence
of
these
cancers
are
widespread
as
depicted
by
this
data,
dispari/es
in
preven/on,
early
treatment,
quality
of
care,
and
outcomes
result
in
higher
morbidity
and
mortality
rates
among
minority
and
underserved
women.
Office
of
the
Na/onal
Coordinator
for
10
Health
Informa/on
Technology
11. The
Challenge
• The
Challenge
calls
on
sohware
developers
to
create
an
applica/on
for
mobile
devices,
in
mul/ple
languages,
that
can
help
underserved
and
minority
women
fight
and
prevent
cancer.
• Providing
general
informa/on
regarding
preven/ve
and
screening
services
for
breast
and
gynecologic
cancers—including,
but
not
limited
to,
benefits,
/ming,
scheduling,
and
loca/on.
• Allowing
for
the
interface
with
pa/ent
health
records
or
provider-‐
sponsored
pa/ent
portals
to
provide
specific
reminders
and
trigger
electronic
health
record-‐based
clinical
decision
support
regarding
the
/ming
of
preven/ve
services.
Office
of
the
Na/onal
Coordinator
for
11
Health
Informa/on
Technology
12. The
Challenge
(cont’d)
• Suppor/ng
the
storage,
viewing,
and
even
the
exchange
of
complex
pa/ent
care
plans.
In
par/cular,
the
applica/on
will
help
strengthen
communica/on
among
provider
care
teams,
possibly
spread
out
across
large
geographic
loca/ons,
to
afford
op/mal
remote
follow-‐up
(e.g.
be
able
to
send
pa/ent
informa/on
to
electronic
health
records
via
Direct,
hZp://directproject.org/).
• Suppor/ng
pa/ent
engagement
and
care
giver
support
with
applica/ons
that
help
pa/ents
and/or
their
caregivers
keep
track
of
complex
care
plans,
such
as
connec/ons
to
community
health
workers,
promotores
de
salud,
or
pa/ent
navigators.
Office
of
the
Na/onal
Coordinator
for
12
Health
Informa/on
Technology
13. Judging
Criteria
• PaHent
engagement:
Incorpora/ng
pa/ent-‐reported
informa/on
• Quality
and
accessibility
of
informaHon:
Providing
high
quality,
evidence-‐based
informa/on
and
interven/ons
using
plain
language,
a
clear
display
that
considers
usability
on
a
small-‐screen
interface
(Web
Usability
and
Aging,
Usability
and
Mobile
Devices),
and
targe/ng
pa/ents
with
a
range
of
health
literacy
levels
• Targeted
and
acHonable
informaHon:
Providing
tailored
informa/on,
recommenda/ons,
and
reminders
• Links
to
online
communiHes
and/or
social
media:
Link
pa/ents
with
others
who
are
facing
the
same
health
challenges
through
social
media
sites
or
organiza/ons,
such
as
the
American
Cancer
Society,
and
to
other
sources
of
support,
such
as
community
health
workers,
pa/ent
navigators,
or
promotores
de
salud
• InnovaHveness
and
usability:
Innova/veness
and
an
easy-‐to-‐use
interface
for
pa/ents
with
a
range
of
experiences
and
comfort
levels
with
technology
• Non-‐English
language
availability:
Availability
of
the
tool
in
languages
used
in
minority
and
underserved
communi/es
Office
of
the
Na/onal
Coordinator
for
13
Health
Informa/on
Technology
14. Timeline
Submission
Period
Begins:
August
23,
2012
Submission
Period
for
Entries
Ends:
February
5,
2013
Evalua/on
Process
for
Entries
Begins:
February
8,
2013
Evalua/on
Process
for
Entries
Ends:
February
19,
2013
Winners
no/fied:
February
24,
2013
Winners
Announced:
Conference
TBD,
March-‐April
2013
Office
of
the
Na/onal
Coordinator
for
14
Health
Informa/on
Technology
15. Prizes
First
Place:
$85,000
+
demo
opp
at
conf
Second
Place:
$10,000
Third
Place:
$5,000
Not
to
men%on:
recogni%on,
publicity,
credibility
and
reach!
Office
of
the
Na/onal
Coordinator
for
15
Health
Informa/on
Technology
16. Ques/ons?
www.health2challenge.org
Contact Hemali:
hemali@health2con.com
Office
of
the
Na/onal
Coordinator
for
16
Health
Informa/on
Technology